From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Function Health, a startup that offers lab testing and body scans for early disease detection, scored nearly $300 million in series B funding, boosting its valuation to $2.5 billion. Redpoint Ventures ...

From electronic health records and blood tests to the stream of data from wearable devices, the amount of health information people generate is accelerating rapidly. Yet, many users struggle to ...

JSR Life Sciences is parting ways with its CRO business Crown Bioscience, selling the unit to a Chinese clinical lab service provider in a deal valued at $204 million (PDF). The new holder of the ...

Update: A minibus spending package passed by the House of Representatives on January 8, 2026, effectively cancels the Mars Sample Return program by eliminating almost all funding for future missions.

This strategic move will enable Crown Bioscience to operate as a standalone entity under Adicon's ownership. Crown Bioscience's comprehensive portfolio of translational oncology services, including ...

SAN DIEGO, November 13, 2025--(BUSINESS WIRE)--JSR Life Sciences LLC ("JSR Life Sciences"), a global leader in life sciences materials and services, today announced it has entered into a definitive ...

The amount of noise The Row’s annual sample sale generated last weekend was perhaps antithetical to the brand’s ultimate quiet luxury status. But what else could be expected? The brand’s legions of ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, reports that Merck KGaA signed a definitive agreement to acquire the chromatography business of JSR Life ...

Companies to Focus on Patterning for Leading-Edge Chips, Including Dry Resist EUV Lithography and Next-Generation Materials Lam, JSR agreement intended to drive the industry's transition to next-gen ...

Lam Research (NASDAQ:LRCX) and JSR Corp. (OTC:JSCPY) announced a non-exclusive cross-licensing and collaboration agreement to accelerate next-generation semiconductor manufacturing. The companies ...